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Abstract
Background: Cardiovascular disease is the most common cause of mortality in haemodialysis (HD) patients and is highly
predicted by markers of chronic inflammation. Regular exercise may have beneficial anti-inflammatory effects, but this is
unclear in HD patients. This study assessed the effect of regular intradialytic exercise on soluble inflammatory factors and
inflammatory leucocyte phenotypes.
Methods: Twenty-two HD patients from a centre where intradialytic cycling was offered thrice weekly and 16 HD patients
receiving usual care volunteered. Exercising patients aimed to cycle for 30 min at rating of perceived exertion of ‘somewhat
hard’. Baseline characteristics were compared with 16 healthy age-matched individuals. Physical function, soluble inflam-
matory markers and leucocyte phenotypes were assessed again after 6 months of regular exercise.
Results: Patients were less active than their healthy counterparts and had significant elevations in measures of inflamma-
tion [interleukin-6 (IL-6), C-reactive protein (CRP), tumour necrosis factor-a (TNF-a), intermediate and non-classical mono-
cytes; all P<0.001]. Six months of regular intradialytic exercise improved physical function (sit-to-stand 60). After 6 months,
the proportion of intermediate monocytes in the exercising patients reduced compared with non-exercisers (7.586 1.68% to
6.386 1.81% versus 6.866 1.45% to 7.886 1.66%; P<0.01). Numbers (but not proportion) of regulatory T cells decreased in the
non-exercising patients only (P<0.05). Training had no significant effect on circulating IL-6, CRP or TNF-a concentrations.
Conclusions: These findings suggest that regular intradialytic exercise is associated with an anti-inflammatory effect at a
circulating cellular level but not in circulating cytokines. This may be protective against the increased risk of cardiovascular
disease and mortality that is associated with chronic inflammation and elevated numbers of intermediate monocytes.
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Introduction
Haemodialysis (HD) patients have a vastly elevated risk of all-
cause, and specifically cardiovascular, mortality [1], which is
the most common cause of death in these patients. This
increased risk of cardiovascular disease (CVD) morbidity and
mortality is multifactorial but includes factors relating directly
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to kidney disease (e.g. the malnutrition–inflammation complex
syndrome) and to the process of HD itself [2]. HD patients have
chronically elevated circulating soluble markers of inflamma-
tion [including interleukin-6 (IL-6), C-reactive protein (CRP) and
tumour necrosis factor-a (TNF-a)] that strongly associate with
mortality and cardiovascular events [3]. Altered inflammatory
immune cell populations and phenotypes are also evident in
HD patients, including a shift towards the ‘pro-inflammatory’
CD16þ monocyte subpopulations [4, 5], which are also strongly
associated with increased cardiovascular mortality in chronic
kidney disease (CKD) [6].
Regular exercise is associated with reduced mortality and
morbidity in various chronic diseases and is associated with a
plethora of cardioprotective benefits [7]. The so-called ‘anti-
inflammatory’ effect of regular exercise may play a key role in
this through a number of different mechanisms. These include
altering the balance of inflammatory immune cell phenotypes,
reducing visceral adipose tissue mass and inflammatory cyto-
kine release and, at higher intensities, through release of a
potent anti-inflammatory cascade stimulated by muscle-
derived cytokines [8, 9]. The importance of promoting an active
lifestyle in the management of kidney disease is recognized in
national and federal guidelines and in the scientific literature,
as evidenced by a recent Cochrane Review [10], but the incorpo-
ration of exercise into clinical service has been slow and lags
behind other long-term conditions. Within the HD population,
patients are frequently inactive and the greater levels of inactiv-
ity are associated with an increased risk of mortality [11, 12].
However, despite reports in the literature of apparent anti-
inflammatory effects of exercise in other patient populations [8,
9], including earlier stage of CKD [13], the impact of regular exer-
cise in HD patients on inflammatory markers, such as CRP, IL-6
and TNF-a, remains unclear [14]. Furthermore, no studies in HD
patients have determined the effect of regular exercise on
inflammatory leucocyte phenotypes known to be central to
chronic systemic inflammatory responses. This study aimed to
determine the impact of a pragmatic 6-month intradialytic
exercise programme on circulating soluble and cellular markers
of chronic systemic inflammation.
Materials and methods
Participants
The study was approved by the East Midlands Research Ethics
Committee (Northampton; 11/EM/0149). Additional ethical
approval for the healthy cohort was granted by the
Loughborough University Ethical Advisory Committee. All par-
ticipants gave written informed consent.
Patients were recruited from two satellite HD units within
the same renal network: one offered an intradialytic exercise
programme as part of clinical care and one did not. An inde-
pendent Consultant Nephrologist verified the medical suitabil-
ity of all patients to exercise. Exclusion criteria for the study
were: <18 years; established contraindications to exercise [15];
lower limb vascular access; recent clinically overt infection;
already taking part in exercise programme; or an insufficient
command of English to consent.
Following recruitment of the patient group, age-matched
healthy participants were recruited from the local area. Healthy
individuals completed a health screen and were ineligible if
they had any history of kidney disease, diabetes, recent infec-
tion, CVD, smoking, or took any drugs known to affect digestion
or metabolism. Healthy individuals donated a one-off serum
blood sample and completed the same outcome measures as
the HD patients (described below) within a laboratory setting.
Exercise programme
The exercise group participated in a progressive intradialytic
exercise programme for 6 months; the non-exercising control
group continued HD treatment as per their usual care. Exercise
was provided in the form of a specially designed recumbent cycle
(Letto series; Motomed, Reck, Germany). Patients aimed to cycle
at a ‘somewhat hard’ rating of perceived exertion (RPE 12–14) [16]
with supervised intradialytic exercise offered thrice weekly. The
exercise programme was designed with a pragmatic approach;
more details are provided in the Supplementary Material.
Randomization
An HD unit providing exercise and a unit not providing exercise
were selected based on practicality and, therefore, the study
was not randomized. All non-exercising patients were eligible
to exercise if such a programme were available at their unit.
This design reduced the sampling bias of using patients unable
to, or not interested in, exercise as controls and ‘exercise-con-
tamination’ of control patients that occurs when control and
exercise patients share shifts.
Outcomemeasures
Blood samples were collected prior to HD at baseline and after
6 months (at least 48 h after previous exercise session); esti-
mated glomerular filtration rate (eGFR) was calculated using the
simplified Modification of Diet in Renal Disease equation [17].
Medical details were extracted from the patients’ clinical notes.
Plasma concentrations of CRP (IBL International GmbH,
Hamburg, Germany), IL-6 and TNF-a (R&D systems, Abingdon,
UK) were determined using commercially available high-
sensitivity enzyme-linked immunosorbent assays. Assessment
of monocyte phenotypes (classical: CD14þþCD16, intermediate:
CD14þþCD16þ and non-classical: CD14þCD16þþ) and regulatory
T cells (Tregs: CD4þCD25þCD127low/) via flow cytometry are
described in the Supplementary Material.
Activity levels were determined using a tri-axial accelerome-
ter (SenseWear, BodyMedia Inc., Pittsburgh, PA, USA). The partici-
pant wore the accelerometer for a single 7-day period collecting
minute-by-minute data. Physical function was assessed using
the sit-to-stand 60 (STS 60) test, which is validated against more
detailed and lengthy assessment methods [18].
Omitted samples
Patients on immunosuppressive therapy were excluded from
analysis of inflammatory factors (Figure 1). Four exercise
patients were omitted from analyses of monocyte phenotype
due to unclear fluorescence patterns. Some patients declined
physical function and activity outcomes; numbers for each out-
come are presented in the Results.
Sample size
Sample size for this study was pragmatic: all eligible patients in
the two dialysis units were invited to participate (Figure 1).
Statistics
Data are presented as mean6 standard deviation or median
(25th–75th percentiles) unless otherwise stated. Baseline
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comparisons between groups were completed using independ-
ent t-tests, non-parametric Mann–Whitney tests or chi-square
tests where applicable. Two-factor mixed-measures analysis of
variance (ANOVA) was used to analyse the effect of exercise:
group (exercise versus control)  time (baseline versus 6
months). Where a significant group  time interaction was
found, post hoc analysis explored the differences using paired
t-tests within groups and independent t-tests for between-
group differences in change from baseline at 6 months.
Comparisons between treatment and non-treatment day activ-
ity levels were assessed using Wilcoxon signed-rank test. Effect
sizes (ES) were calculated using Cohen’s D [19].
All statistical analyses were completed on Statistical
Package for Social Sciences (SPSS v.21, IBM, New York, NY, USA).
Statistical significance was accepted at P< 0.05.
Results
Recruitment and participant flow
A total of 38 HD patients participated in the study (Figure 1).
Twenty-two patients were recruited into the exercise group, of
whom 16 completed the 6-month study period (27.3% attrition
rate). Sixteen non-exercising control HD patients volunteered,
of whom 15 completed the study. Sixteen healthy participants
volunteered and blood samples were obtained from 15.
Implementation of intervention
The exercising patients participated in 386 12 exercise sessions.
The mean session duration was 35 (30–42) min with patients
exercising at 6368 r.p.m. and perceiving the exercise to be
‘somewhat hard’ [RPE: 12 (11–13)]. Mean power output was
1667 W.
Participant characteristics
The age and sex of the HD patients and healthy participants
were similar (Table 1). The age of the exercising and non-
exercising HD groups were different (57.06 10.5 versus
70.2613.7 years; P¼ 0.005), with more South Asian patients in
the exercise group (7/16 versus 1/15; P¼ 0.02), which reflected
the demographic of the centres where recruitment took place.
However, there were no differences in circulating or cellular
inflammatory markers between the exercising and non-
exercising groups.
Outcomes
Inflammatory markers. HD patients had significantly higher con-
centrations of circulating IL-6 (ES¼ 1.32), TNF-a (ES¼ 1.37) and
CRP (ES¼ 1.35) than the healthy participants (Table 2).
Patients at exercising HD unit
Assessed for eligibility (n=104)
Excluded  (n=82)
• Not meeting inclusion criteria (n=79)
• Declined to participate (n=3)
Analysed  (n=16)
• Excluded from analysis of 
inflammatory markers (n=1) –
immunosuppressive therapy
Allocated to intervention (n=22)
Lost to follow-up (n=1)
• Transplant (n=1)
Allocated to intervention (n=16)
Analysed  (n=15)
• Excluded from analysis of 
inflammatory markers (n=2) –
immunosuppressive therapy
Analysis
Follow-Up
Enrollment and 
Allocation
Patients at non-exercising HD unit
Assessed for eligibility (n=78)
Excluded  (n=62)
• Not meeting inclusion criteria (n=58)
• Declined to participate (n=4)
Lost to follow-up (n=6)
• Transplant (n=1)
• Death (n=1)
• Insufficient exercise (n=1)
• Infection / injury (n=2)
• Other morbidity (n=1)
Fig. 1. Consolidated Standards of Reporting Trials diagram.
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Circulating concentrations of IL-6, CRP and TNF-a did not dif-
fer between the exercising and non-exercising patients at base-
line (Table 2). ANOVA found no interaction or main effects in
response to the 6-month exercise programme (Figure 2a–c).
Monocytes. The proportion and number of intermediate
(ES¼ 1.23 and ES¼ 1.17, respectively) and non-classical mono-
cytes (ES¼ 1.56 and ES¼ 1.31) were significantly greater in HD
patients compared with healthy participants (Table 2).
There were no significant baseline differences between the
exercising and non-exercising HD patients in the proportion of
classical, intermediate or non-classical monocytes (Table 2).
ANOVA revealed a significant group  time interaction in the
proportion (F¼ 10.4, P¼ 0.004) and number (F¼ 4.91, P¼ 0.04) of
intermediate monocytes between the exercising and non-
exercising HD patients, whereas classical and non-classical
monocytes did not show any significant effects (Figure 2d–f).
Post hoc tests showed a trend for reduced proportion of inter-
mediate monocytes in the exercising patients (7.5861.68% to
6.3861.81%; P¼ 0.08, ES¼ 0.68), and an increase in non-
exercising HD patients (6.8661.45% to 7.8861.66%; P¼ 0.02,
ES¼ 0.65). The magnitude of change in the proportion of inter-
mediate monocytes observed in the exercising patients was sig-
nificantly different from the non-exercising patients (P¼ 0.004).
Table 1. Participant characteristicsa
Healthy group
(n ¼ 16)
Combined
HD patients
(n ¼ 31) P-value
Exercising
HD patients
(n ¼ 16)
Non-exercising
HD patients
(n ¼ 15) P-value
Age (years) 61.56 10.9 63.4613.7 0.63 57.0610.5 70.26 13.7 0.005*
Gender (male/female) 8/8 18/13 0.37 8/8 10/5 0.35
Weight (kg) 75.36 16.6 75.9623.1 0.92 71.0624.9 81.26 20.6 0.23
BMI (kg/m2) 26.16 5.0 27.166.4 0.58 25.966.7 28.46 6.1 0.29
Systolic blood pressure (mmHg) 1296 13 136621 0.16 135624 1386 19 0.68
eGFR (mL/min/1.73 m2) 1026 22 b – b b –
Number of comorbidities – – – 462 46 2 0.57
aData are presented as mean6 standard deviation.
bAll HD patients had established end-stage renal disease and had received HD treatment for at least 3 months.
*Denotes a significant difference between exercising HD patient and non-exercising HD patient groups.
Table 2. Comparisons in markers of inflammation and haematology at baseline between a healthy group and HD patients, and between the
exercising and non-exercising HD groupsa
Healthy group HD group P-value
Exercising
HD group
Non-exercising
HD group P-value
Markers of inflammation (n ¼ 15 and n ¼ 28) (n¼ 15 and n ¼ 13)
IL-6 (pg/mL) 0.81 (0.43–1.76) 4.63 (2.73–7.09) <0.001* 5.3963.05 4.9262.79 0.68
TNF-a (pg/mL) 0.96 (0.60–1.73) 3.21 (2.66–4.62) <0.001* 3.22 (2.72–4.24) 3.20 (2.64–4.67) 0.77
CRP (mg/L) 0.83 (0.21–1.90) 4.61 (2.68–9.78) <0.001* 3.99 (2.34–6.86) 7.89 (3.39–10.4) 0.37
Classical monocytes (%)b 89.5 (87.0–92.1) 80.3 (72.6–82.2) <0.001* 80.5 (75.4–82.3) 79.8 (72.6–80.9) 0.53
Classical monocytes (cells/mL)b 5066 130 5166 112 0.78 435 (410–525) 580 (558–599) 0.09
Intermediate monocytes (%)b 4.34 (3.74–4.95) 6.77 (5.98–8.47) <0.001* 7.5861.68 6.8661.45 0.27
Intermediate monocytes (cells/mL)b 21.8 (19.4–29.1) 45.9 (40.5–52.3) <0.001* 46.3614.7 49.4614.2 0.61
Non-classical monocytes (%)b 6.45 (4.2–8.5) 13.6 (11.2–17.7) <0.001* 12.4 (10.8–16.4) 13.8 (12.7–17.5) 0.36
Non-classical monocytes (cells/mL)b 30.0 (23–50) 90.9 (72.2–124.5) <0.001* 75.9 (59.9–105.7) 96.9 (89.0–139.2) 0.11
Tregs (%)c 7.676 0.98 6.756 1.53 0.02* 6.9361.77 6.5561.24 0.53
Tregs (cells/mL) 20.1 (18.6–25.0) 23.7 (17.3–36.0) 0.53 23.6 (16.0–38.0) 23.8 (19.1–32.4) 0.57
CD4þ lymphocytes (%)c 20.2 (17.4–23.9) 24.1 (20.1–28.9) 0.18 23.968.0 24.767.2 0.79
CD4þ lymphocytes (cells/mL) 264 (227–369) 366 (269–493) 0.05* 317 (253–496) 369 (301–483) 0.53
Haematology (n ¼ 15 and n ¼ 31)
Haemoglobin (g/L) 1346 17 1186 12 0.003* 126 (118–131) 105 (102–110) <0.001†
Red blood cells (1012/L) 4.496 0.44 3.676 0.48 <0.001* 3.8160.58 3.55 0.14
White blood cells (109/L) 5.146 0.95 7.056 2.56 0.001* 6.6462.44 7.47 0.38
Neutrophils (109/L) 2.8 (2.4–3.5) 3.9 (3.0–5.6) 0.005* 3.6 (2.9–5.6) 4.3 (3.7–5.9) 0.32
Monocytes (109/L) 0.5 (0.5–0.7) 0.7 (0.5–0.8) 0.24 0.6 (0.5–0.7) 0.7 (0.6–0.8) 0.054
Lymphocytes (109/L) 1.56 0.4 1.66 0.6 0.45 1.5860.66 1.68 0.67
aData are presented as mean6 standard deviation or median (25th–75th percentiles). P-values are derived from independent t-tests or Mann–Whitney test, where
applicable. Classical monocytes refer to CD14þþCD16; intermediate monocytes to CD14þþCD16þ; non-classical monocytes to CD14þCD16þþ. Tregs (%) and (cells/mL)
refer to the percentage and number of CD4þ lymphocytes that are CD25þCD127low/.
bFor monocytes n¼24 for HD group; n¼11 for exercise HD group and n¼13 for non-exercising HD group.
cFor percent Tregs and percent CD4þ lymphocytes n¼ 16 for healthy group.
*Denotes a significant difference between healthy and HD groups.
†
Denotes a significant difference between exercising and non-exercise groups.
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Tregs. The number of circulating CD4þ lymphocytes were higher
in the HD patients compared with the healthy participants
(ES¼ 0.71, Table 2). However, the proportion of circulating CD4þ
lymphocytes that were Tregs was lower in the HD patients
(ES¼ 0.72, Table 2). The number of Tregs did not differ between
groups.
At baseline, there were no significant differences between
the exercising and non-exercising HD patients in the proportion
or number of Tregs or CD4þ lymphocytes (Table 2).
ANOVA revealed group  time interactions in the proportion
and number of CD4þ lymphocytes (F¼ 11.3, P¼ 0.002 and F¼ 12.7,
P¼ 0.001, Figure 2h). In both cases, post hoc paired t-tests revealed
a significant decrease in the non-exercising patients from base-
line to 6 months (P< 0.001, ES¼ 0.67 and P¼ 0.001, ES¼ 0.61,
respectively) with no significant change in the exercise group.
ANOVA also revealed a group  time interaction in the num-
ber of Tregs (F¼ 9.89, P¼ 0.004). Post hoc paired t-tests revealed a
trend for an increase in exercising patients (P¼ 0.10, ES¼ 0.23)
and a decrease in non-exercising patients (P¼ 0.003, ES¼ 0.50;
Figure 2g). The magnitude of change in the number of Tregs
observed over the 6 months in the exercising patients was signifi-
cantly different from that seen in the non-exercising patients
(P¼ 0.02). There was no change in the proportion of CD4þ lym-
phocytes that were Tregs (interaction: P¼ 0.74, Figure 2i).
Physical function. Compared with healthy participants, HD
patients had significantly lower levels of physical function, as
measured by the STS 60 test (ES¼ 1.28, Table 3).
At baseline, there were no significant differences between
the exercising and non-exercising HD groups (P¼ 0.88). Change
in physical function was different between groups (F¼ 28.1,
P< 0.001, Figure 3), with increases in the exercise group
(P< 0.001, ES¼ 1.47), but not the non-exercising group (P¼ 0.21,
ES¼ 0.18).
Fig. 2. Changes in indices of systemic inflammation after 6 months in the exercise and non-exercise HD patients. (a) IL-6; (b) CRP; (c) TNF-a; the proportion of mono-
cytes that are (d) classical, (e) intermediate, (f) non-classical phenotype; (g) number of Tregs; (h) number of CD4þ lymphocytes; (i) proportion of CD4þ lymphocytes that
are Tregs. Each black square and circle represent an exercising and non-exercising patient, respectively; bars show mean 6 standard error of the mean. Asterisks
denotes a significant difference in change between exercising and non-exercising patients (P< 0.05). Exercising patients: n ¼ 15 (except for monocytes where n ¼ 11),
non-exercising patients: n ¼ 13.
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Activity levels. Twenty-four HD patients and 16 healthy partici-
pants provided usable accelerometer data. Habitual activity lev-
els were lower in the HD patients than the healthy cohort (Table
3). The number of steps completed each day (ES¼ 1.14) and the
time spent being physically active were greater in the healthy
group (ES¼ 0.50). There were no differences between HD sub-
groups (Table 3).
Patients’ activity levels were significantly reduced on HD
treatment days compared with non-treatment days, includ-
ing number of steps [2100 (1643–3015) versus 3279 (2350–5055)
steps/day; P< 0.001, ES¼ 0.38] and non-sedentary time [52.4
(15.7–95.5) versus 57.2 (27.5–106.0) min/day; P¼ 0.04,
ES¼ 0.05].
Anthropometric and clinical parameters. Regular exercise did not
induce changes in weight, body mass index (BMI), resting blood
pressures, medications or haematology (all P> 0.05).
Discussion
This study is the first to demonstrate that completion of a
6-month intradialytic exercise programme promotes a shift
away from the pro-inflammatory and pro-atherogenic inter-
mediate monocyte phenotype towards an anti-inflammatory
circulating leucocyte profile, as evidenced by an increase in the
number of the anti-inflammatory Treg phenotype, compared
with non-exercising patients. We also confirm elevated circulat-
ing and cellular markers of systemic inflammation in HD
patients compared with an age-matched healthy cohort: CRP,
IL-6 and TNF-a were significantly elevated in the HD cohort, the
proportion of Tregs was reduced and monocyte populations
shifted towards intermediate and non-classical phenotypes.
Physical activity levels and physical function were also lower in
HD patients.
This is the first study in any clinical population to show that
exercise training selectively diminishes the proportion of mono-
cytes within the inflammatory intermediate subset. Elsewhere,
in an inactive elderly, but healthy group, 12 weeks of thrice
weekly endurance and resistance exercise training significantly
reduced the percentage of CD14þCD16þ monocytes and
decreased the TNF-a response to lipopolysaccharide stimulation
[20]. However, CD16þ monocytes were not analysed separately as
intermediate and non-classical subsets, as this is a relatively
new classification system [21]. Whether the present findings are
applicable to populations other than HD patients is not known,
but may explain these previous observed changes in ‘CD16þ’
monocytes.
Elevations in circulating intermediate monocytes are associ-
ated with an increased cardiovascular risk in non-CKD, CKD and
HD patients [4, 6, 22] and have been described as a promising
therapeutic target for CVD in CKD [23]. In agreement with the
present study, the number and proportion of intermediate mono-
cytes are increased in HD patients compared with healthy
cohorts [4, 5]. Intermediate monocytes secrete pro-inflammatory
cytokines (TNF-a, IL-1b and IL-6), express toll-like receptor 4 and
adhesion molecules (CCR5 and CX3CR1) and exhibit spontaneous
reactive oxygen species production [24–26], all considered mecha-
nisms for cardiovascular dysfunction. The reduction in inter-
mediate monocytes that we report here is encouraging as it may
be a mechanism by which exercise protects against systemic
inflammation and associated cardiovascular disorders in HD
patients.
In the present study, the proportion of CD4þ lymphocytes
that were Tregs was lower in HD patients than in the healthy
group. Reduced Treg capacity has been reported previously in
HD patients [27, 28]. Abnormalities in Treg activity are harmful;
deficiencies are associated with autoimmunity, inflammation
and allergy, whereas over-activation is associated with
increased risk of chronic infections and tumour growth [29].
The diminished Treg capacity in HD patients may contribute to
chronic immune activation and inflammation typically exhib-
ited in this population.
Table 3. Comparisons in physical activity and function between a healthy group and HD patients, and between the exercising and non-exercis-
ing HD groupsa
Healthy group HD group P-value
Exercising
HD group
Non-exercising
HD group P-value
Physical activity and function (n¼ 16) (n¼ 24) (n¼ 10) (n¼ 14)
Energy expenditure (kJ/day) 105056 1495 94466 2368 0.12 93156 2703 95406 2200 0.82
Steps (per day) 7594 (5847–9539) 2934 (2058–4460) <0.001* 2237 (1995–3902) 3234 (2527–4462) 0.47
Time being physically active (min/day) 105 (86–142) 55 (26–98) 0.009* 63 (49–102) 51 (16–87) 0.26
Time being sedentary (min/day) 1335 (1295–1354) 1385 (1342–1413) 0.009* 1389 (1353–1424) 1376 (1338–1390) 0.26
STS 60 (reps)b 286 13 136 9 0.001* 136 10 136 9 0.84
aData are presented as mean6 standard deviation or median (25th–75th percentiles). P-values are derived from independent t-tests or Mann–Whitney test, where
applicable.
bFor STS 60: n¼23 for HD group, n¼11 for exercise HD group and n¼12 for non-exercising HD group.
*Denotes a significant difference between healthy and HD groups.
Fig. 3. STS 60 score at baseline and 6 months in exercising and non-exercising
HD patients. Lines represent individual patients; grey bars show the mean.
Asterisk denotes a significant change from baseline (P<0.001); exercise group:
n ¼ 11, non-exercising group: n ¼ 12.
818 | M. Dungey et al.
Downloaded from https://academic.oup.com/ckj/article-abstract/10/6/813/3089987
by Loughborough University user
on 29 January 2018
The favourable change in the number of Tregs in the exercise
group after 6 months compared with the non-exercising group
may represent enhanced anti-inflammatory capacity. Sedentary
but otherwise healthy individuals have demonstrated lower
numbers of Tregs than physically active groups and antigen-
stimulated IL-10 release correlates with this cell population [30].
However, as we found no change in the proportion of CD4þ lym-
phocytes that were Tregs, the increase we observed may simply
relate to differences in overall CD4þ numbers. This is further sup-
ported by the observation that the number of CD4þ lymphocytes
decreased significantly in the non-exercising group but not in the
exercise group. Therefore, it is not clear whether the enhanced
Treg population in the exercise group actually represents a true
anti-inflammatory adaptation.
Circulating CRP, IL-6 and TNF-a were not improved after
6 months of regular intradialytic exercise in this study.
Examination of the literature to date reveals that no well-
controlled trials have reported significant meaningful reduc-
tions in these soluble inflammatory markers after exercise
training in HD patients [14]. Well-designed studies have
reported no change in CRP after 3–4 months of intradialytic
cycling or extradialytic resistance training [31, 32], or with main-
tained CRP but no improvement in IL-6 or TNF-a [33, 34]. In pre-
dialysis CKD cohorts, resistance exercise that increases muscle
mass [35] and regular walking exercise have been shown to
favourably alter circulating inflammatory factors [13].
In a large cohort of healthy individuals (n¼ 4289), physical
activity was associated with reduced CRP and IL-6, and
increasing activity levels reduced markers of inflammation over
a 10-year follow-up [36]. Therefore, for these soluble inflamma-
tory markers, a large cohort or a long exercise intervention may
be required to detect meaningful change. This is likely exacer-
bated in HD patients by the large intra- and inter-individual var-
iation of IL-6, CRP and TNF-a. The day-to-day variation (i.e. due
to fluid overload, recurrent infections, HD itself) in this popula-
tion may limit the use of CRP and circulating cytokines in isola-
tion to detect long-term change.
Previous studies have demonstrated sedentary behaviour in
HD patients [11, 37], but the extent of inactivity is worth high-
lighting. Significantly, the least active HD patients have a 62%
increased mortality risk [12] and those with the lowest physical
function have higher hospitalization rates and all-cause mortal-
ity [38, 39]. A recent Cochrane Review concludes there are vari-
ous benefits of increasing physical activity for health and well-
being in CKD [10], and the present study adds to this body of evi-
dence. Despite the seemingly low power output the exercise
group improved physical function. This improvement was prob-
ably augmented by low baseline values giving greater potential
for improvement. Increasing physical function has a positive
impact on quality of life and is valued very highly by patients;
therefore, promotion of this key outcome is likely to be more
effective in encouraging continued participation in physical
activity.
This exercise programme was limited to one mode and pre-
scription of exercise and was not standardized per patient; dif-
ferent exercise modalities, at different times or intensities, may
have different results. Nonetheless, this study makes a major
contribution because it was pragmatic in design, thereby ascer-
taining a realistic response to an achievable intradialytic pro-
gramme per se in a naturally heterogeneous HD cohort. There
was, therefore, expected variation in the absolute exercise
intensity achieved in this study (comparable to other studies
[31, 40]); however, subjective intensity remained quite consis-
tent, as evidenced by RPE.
For reasons of practicality and to avoid sampling bias and
‘exercise-contamination’ of control patients that occurs when
control and exercise patients share shifts, this study was not
randomized. This led to different demographics between the
exercising and non-exercising groups, including ethnicity and
age, but did not confound the key outcome measures. Likewise,
haemoglobin was different between groups at baseline, but as
this did not change over time, it is unlikely to have influenced the
findings. Finally, the small sample size is due to the practicalities
of running such a study despite approaching all eligible patients.
This pragmatic evaluation of intradialytic exercise provides
important novel evidence into anti-inflammatory adaptations
that provides a primary point of reference for future investiga-
tions into the therapeutic benefits of exercise in this population.
Conclusions
HD patients are sedentary and demonstrate high levels of
chronic inflammation, yet we show for the first time that under-
taking regular exercise during HD has an anti-inflammatory
effect at a circulating cellular level. The reduction in intermediate
monocytes may be protective against the substantially increased
risk of cardiovascular morbidity and mortality and further sup-
ports the therapeutic potential of regular exercise in these
patients.
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